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Risk assessmenta b s t r a c t
A large number of emerging contaminants (ECs) are known to persist in surface waters, and create
pressure onwastewater treatment works (WWTW) for their effective removal. Although a large database
for the levels of these pollutants in water systems exist globally, there is still a lack in the correlation of
the levels of these pollutants with possible long-term adverse health effects in wildlife and humans, such
as endocrine disruption. The current study detected a total of 55 ECs in WWTW influent surface water,
41 ECs in effluent, and 40 ECs in environmental waters located upstream and downstream of the plant. A
list of ECs persisted through the WWTW process, with 28% of all detected ECs removed by less than 50%,
and 18% of all ECs were removed by less than 25%. Negative mass balances of some pharmaceuticals and
metabolites were observed within the WWTW, suggesting possible back-transformation of ECs during
wastewater treatment. Three parental illicit drug compounds were detected within the influent of the
WWTW, with concentrations ranging between 27.6 and 147.0 ng L1 for cocaine, 35.6e120.6 ng L1 for
mephedrone, and 270.9e450.2 ng L1 for methamphetamine. The related environmental risks are also
discussed for some ECs, with particular reference to their ability to disrupt endocrine systems. The
current study propose the potential of the pharmaceuticals carbamazepine, naproxen, diclofenac and
ibuprofen to be regarded as priority ECs for environmental monitoring due to their regular detection andr Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
E. Archer et al. / Chemosphere 174 (2017) 437e446438persistence in environmental waters and their possible contribution towards adverse health effects in
humans and wildlife.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
There is growing evidence that a variety of pharmaceuticals and
personal care products (PPCPs) persist in natural freshwater re-
sources (Kasprzyk-Hordern et al., 2009; Bahlmann et al., 2014;
Petrie et al., 2014; Blair et al., 2015). These organic pollutants are
considered a part of emerging contaminants (ECs), which enter
water systems from various sources, such as human excretion
(sewage), wrongful disposal, leeching from landfill, drain water, or
from industries. Even though it has been reported that these ECs
are typically present at low environmental concentrations (ng/l to
mg/l range), it is still unclear whether the levels of these compounds
present in environmental waters can cause undesired physiological
effects in wildlife and humans.
Research has shown that several regularly-used PPCPs may
mimic or alter different vertebrate endocrine system pathways,
which are collectively referred to as endocrine-disrupting con-
taminants (EDCs) (Schlumpf et al., 2001; Boberg et al., 2010;
Veldhoen et al., 2014). Several PPCPs have been shown to be
persistent or pseudo-persistent during wastewater treatment,
thereby posing potential risk when discharged in environmental
waters (Kasprzyk-Hordern et al., 2009; Verlicchi et al., 2012; Petrie
et al., 2014). The prioritisation of these ECs for risk assessment is
difficult, because concentrations in environmental waters show
huge variation (Verlicchi et al., 2012; Petrie et al., 2014; Matongo
et al., 2015), and their effects at sub-lethal concentrations are not
yet well established. Studies reporting on the detection of PPCPs in
South African water systems have only increased in the past few
years (Agunbiade and Moodley, 2014/2016; Amdany et al., 2014;
Madikizela et al., 2014; Matongo et al., 2015). These studies
focussed on the detection of several classes of PPCPs and the
plasticizer bisphenol-A, with concentrations regularly surpassing
the mg L1 level in WWTW effluent and environmental waters.
However, with the vast majority of ECs shown to be present in
wastewater and environmental waters on a global scale, their fate
and environmental effects within WWTWs and environmental
waters are still poorly described.
Apart from the ubiquitous detection of PPCPs in South African
surfacewaters, the detection of illicit drugs and other drugs of abuse
are poorly investigated. Although illicit drug usage is shown to be on
the rise in SouthAfrica (Dada et al., 2015), the sources of information
for drug abuse in the country are largely limited to law enforcement
and treatment centre data. However, these sources may underesti-
mate the extent of drug abuse. A promising approach to estimate
illicit drug use include sewage epidemiology, which estimates drug
consumption through the detection of illicit drugs and their me-
tabolites in wastewater (Baker and Kasprzyk-Hordern, 2013).
The present study focused on the daily loads and fate of ECs and
metabolites in the aqueous phase of a WWTW influent and
effluent, as well as in surface waters in a river system located up-
stream and downstream of the plant. This study is a first to verify
the detection and fate of a large list of PPCPs, metabolites, and illicit
drugs at a South AfricanWWTW. A further aimwas to correlate the
persistence of selected ECs detected during the study with data
showing modulation of wildlife reproductive and thyroid systems,
with reference to established adverse outcome pathway (AOP)
frameworks.2. Materials and methods
2.1. Chemicals and materials
The study included the screening for 90 ECs including 38
deuterated internal standards for the method development. All the
reference standards were supplied by the Department of Chemistry
at the University of Bath (Bath, UK; see Petrie et al., 2016 for further
details). All chemicals were prepared at either concentrations of 0.1
or 1 mg mL1 in the relevant solvents and stored in the dark
at 20 C. All glassware were deactivated using dimethyl-
chlorosilane (DMDCS) in toluene (5% v/v) to limit the sorption of
basic chemicals to glass surfaces. Both the MeOH and toluene used
for experimentation were obtained from Sigma-Aldrich (99%, HPLC
grade).
2.2. Study site and sampling procedures
The site of study was at a WWTW situated in the Gauteng
Province of South Africa (Fig. 1; Fig. S1). Treated wastewater
effluent is discharged into a nearby river, which joins other streams
that eventually feeds into a major dam that supplies approximately
6% of the total municipal drinking water to the surrounding
communities.
Sampling was done over five consecutive days during themonth
of July 2015 (Monday to Friday). Influent and effluent samples were
taken each day at 60 min intervals (100 mL h1) from the WWTW
influent (after grit screens) and effluent (after chlorination), upon
which a final composite sample (100 mL) was obtained for each
sampling location per day. The influent and effluent samples were
taken concurrently and notmatched to the hydraulic retention time
of the WWTW. Grab samples of river surface water (100 mL) were
taken at a location upstream (100m) and downstream (3.5 km from
the point of discharge) of the WWTW (Fig. 1). All samples were
transported on ice from the sampling sites to the laboratory and
were kept cold (±4 C) and in the dark until analyte extraction,
which was done within a maximum time of 10 h.
2.3. Extraction procedure
The collected water samples were adjusted to a pH of 7 (±0.2)
and filtered using 0.45 mmpore size PTFE filters prior to solid-phase
extraction (SPE). Each 100 mL water sample from the various lo-
cations were split into two 50 mL samples to allow for duplicate
extraction of each locality and between each day of sampling. Each
sample included 50 ng of each of the deuterated PPCP internal
standard and was mixed well before extraction. The water samples
were extracted using Oasis® HLB (3 cc, 60 mg) SPE cartridges
(Waters; Microsep, Johannesburg, South Africa). The cartridges
were conditioned with 2 mL methanol, followed by 2 mL of ultra-
pure water (Millipore) at a flow rate of 1 mL min1. After condi-
tioning, the water samples (50 mL) were passed through the SPE
cartridges at a flowrate of 5 mL min1 and allowed to run dry for a
minimum period of 15 min. The dried cartridges were kept frozen
(20 C) until all sampling were completed, from which the car-
tridges were then sent to the University of Bath (United Kingdom)
for chemical analysis within 10 days of extraction. Each cartridge
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styrene pack lined with ice packs. Upon arrival at the University of
Bath, the cartridges were dried and eluted with 4 mLMeOH using a
manifold at a flow rate of 1 mL min1. The extracts were dried
under a gentle stream of nitrogen using a TurboVap evaporator
(Caliper, UK, 40 C, N2, <5 psi) and the evaporated samples were re-
suspended in 500 mL of a H2O:MeOH (80:20) solvent, giving a 100
concentrated sample, and transferred to polypropylene MS vials
(Waters, Manchester, UK) for chromatography.2.4. Liquid chromatography e mass spectrometry
A Waters Acquity UPLC system coupled to a Xevo Triple Quad-
rupole Mass Spectrometer (UPLC/TQD-MS; Waters, Manchester,
UK) was used following the method described by Petrie et al.
(2016). Two separate chromatography methods were used for the
quantification of acidic and basic compounds, as further described
in the supplementary information (Fig. S2). In essence, both
methods used a reversed-phase BEH C18 column (150  1.0 mm,
particle size e 1.7 mm; Waters, Manchester, UK) coupled with a
0.2 mm (2.1 mm) in-line column filter. Mobile phase flow rates and
injection volumes were maintained at 0.04 mL min1 and 15 mL
respectively for both methods. Argon was used as the collision gas,
and nitrogen as the desolvation and nebulising gas. Solvent blanks
containing H2O:MeOH (80:20) were inserted after each ten sam-
ples, and two solvent blanks after quality control (QC) samples of
the internal standards. The corrected recoveries of the analysed
compounds are shown in the supplementary information
(Table S1).2.5. Calculations
The mass loads of the target analytes in the aqueous phase at
both the influent and effluent of the WWTW during the sampling





¼ ðInf or Eff *FR*1=1000Þ (1)
where Inf and Eff refers to the concentration (in ng L1) of the
analytes detected at the influent and effluent wastewater samples,
and FR refers to the mean flow rate of the plant (ML day1) during
each sampling day. The ability of the WWTW to remove the
detected compounds in the aqueous phase were determined by
calculating the percentage removal efficiency (RE %) between
influent and effluent wastewater during the sampling period using
Equation (2):
REð%Þ ¼ ððInf  Eff Þ=Inf Þ*100 (2)
where Inf refers to the mass loads (g day1) of the analytes detected
at the influent sample site of the plant, and Eff refers to the mass
loads (g day1) of the analytes detected at the effluent sample site
of the plant.2.6. Statistical analysis
Statistical analyses were performed using Statistica (version
13.0). Concentrations of the ECs detected at the WWTW influent
and effluent, as well as water samples located upstream and
downstream of the plant during the sampling period were
compared using a repeatedmeasure mixed-model ANOVAwith the
sampling day as a random factor. Significant differences were
recorded as p < 0.05.3. Results and discussion
3.1. Analysis of WWTW samples
A total of 55 ECs were detected in wastewater influent, and
41 ECs in effluent samples, which represented 19 classes of PPCPs,
human indicators, illicit drugs and metabolites (Fig. 2; Table S2).
The human indicators contained chemicals which are associated
with endogenous products of humanmetabolism orwhich are used
for population equivalent estimates. Although flow data (ML day1)
from each day was incorporated to calculate the mass loads of the
ECs within theWWTWduring the sampling period, the variation in
themass loads of the ECs between sampling days may be attributed
to several factors, such as the variation in the daily human usage of
these compounds, pollution events from surface water sources
leading towards the plant, the retention time of wastewater within
the plant, or the overall performance of the treatment processes
within the sampling period.
The WWTW sampled in the current study showed varying
removal efficiencies of the detected ECs (Table S3) and conforms to
similar removal data of PPCPs reported in other studies (Verlicchi
et al., 2012; Bahlmann et al., 2014; Petrie et al., 2014; 2016). By
comparing the average mass loads of the ECs at the influent and
effluent, it was calculated that 28% of all detected ECs were
removed by less than 50%, and 18% of all ECs were removed by less
than 25% (Fig. 3). A significant increase in final effluent concen-
tration of the pharmaceutical metabolite desvenlafaxine (from
venlafaxine; p ¼ 0.039), were measured compared to influent
wastewater (negative mass balance). Also, a significant average
negative mass balancewas observed for the antibiotic azithromycin
(p ¼ 0.001; Fig. 3). Negative mass balances were also calculated
based on the average mass load concentrations for the pharma-
ceutical metabolites 10,11-dihydro-10-hydroxycarbamazepine and
O-desmethyltramadol, as well as the parental compound tramadol
(Fig. 3). However, statistical analysis deemed these negative mass
balances non-significant due to the variation between sampling
days (p > 0.05).
Two potential explanations for the occurrence of negative mass
balances for ECs in WWTWs have been postulated, namely: i)
persistent ECs accumulate in aggregates, leading to subsequent
dissolution through biotic or abiotic processes, and/or ii), metabo-
lites and/or conjugate forms of ECs are not detected at the WWTW
influent and are subsequently back-transformed or de-conjugated
into parental compounds through either biotic or abiotic pro-
cesses within the WWTW (Verlicchi et al., 2012; Blair et al., 2015).
For example, conjugate forms of ethynyl-estradiol (EE2), carba-
mazepine and diclofenac have been shown to be de-conjugated by
bacterial cultures (Vieno et al., 2007; Lee et al., 2012; Aris et al.,
2014), while metabolites of the antibiotic sulfamethoxazole were
shown to be transformed to its parental compound by photolytic
processes (Bonvin et al., 2013). Although not all metabolites and
conjugate forms of ECs can be regarded to be easily transformed
within wastewater, it is possible that the perceived recalcitrance of
some compounds in the current study at the WWTW (such as
carbamazepine, tramadol, sulfamethoxazole and NSAIDs) may
partly be caused by a combination of biotic and/or abiotic events
leading towards the transformation of parental compounds and
their metabolites.
The recalcitrance of certain ECs (such as tramadol) is well-
known. Tramadol, is rapidly metabolised in the liver by desme-
thylation enzymatic activities encoded by the Cytochrome P450
gene (CYP2D6), which give rise to its two primary metabolites O-
desmethyltramadol (ODT) and N-desmethyltramadol (NDT)
(Ardakani and Rouini, 2007). Only 10e30% of the parental tramadol
is excreted in sewage, and hence, a large amount of the primary or
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(Ardakani and Rouini, 2007). It is also noteworthy to mention that
levels of the enzyme CYP2D6 may vary significantly between hu-
man individuals and sex. Taken that the WWTW screened during
the current study receives wastewater from public, domestic and
industrial sources, the daily levels of ECs (such as tramadol and its
primary metabolites) in wastewater may vary greatly according to
the de facto population contributing sewage of the WWTW. Parti-
tion coefficients for tramadol (log Kow 3.01) and its metabolites
ODT and NDT (log Kow 2.45; EPI Suite v4.11, KOWWIN, v1.68 esti-
mate) are shown to be high, which is indicative of a tendency to-
wards sorption onto organic constituents within soil, sediment
and/or sludge. Therefore, tramadol will tend to bio-accumulate or
bio-concentrate in organisms (such as microbes) within the water
body. Such association with microbial aggregates and solids may
protect these compounds from degradation until release. Floc
breakup in the sludge and other forms of decay may then lead to
association-disassociation events that may explain the large vari-
ation in metabolite levels.
Apart from the possible transformation of parental and/or
metabolite ECs in wastewater, a number of factors could also
potentially contribute to the attenuation and biodegradation of ECs
in WWTWs. These include climatic conditions, physiochemical
properties of the ECs, the hydrological retention time of the
WWTW, and the microbial activity within the plant during the
sampling period. The latter will include the properties of the
extracellular polymeric substances (EPS) produced by microbial
biofilms to absorb organic and inorganic pollutants (Writer et al.,
2011; Petrie et al., 2014). It is possible that, unless some of these
ECs are fortuitously co-metabolised, the energy that can be gained
bymicroorganisms via degrading them at the low, environmentally
relevant concentrations would not warrant the energy inputFig. 1. Location map of the WWTW, point of discharge into the receiving warequired for enzyme production for further biodegradation.
Furthermore, it was shown that environmentally relevant con-
centrations of the antibiotics phenazone, amoxicillin, and eryth-
romycin can affect the initial adhesion of bacteria onto surfaces
(Schreiber and Szewzyk, 2008), and that a specialist degradative
strain of yeast had a lesser habitat range than non-degradative
strains in soil (Barratt et al., 2003). Admittedly speculative, it is
possible that such a shift, together with the availability of labile
nutrients at relatively high concentrations may favour generalists
to dominate the microbial community at the expense of specialist
degraders, causing ECs to pass through unaltered.
3.2. Detection of illicit drugs at the WWTW
During the current study, eight ECs classified as illicit drugs,
their metabolites, and a drug precursor were identified in waste-
water influent (Fig. 2). An increase in the loads of breakdown
products and precursors of amphetamine-type stimulants (ATS)
were observed at the WWTW (pseudoephedrine
> norephedrine > amphetamine >methamphetamine) (Fig. 2). The
ATS mephedrone was detected only at influent samples, ranging
from 36 to 121 ng L1 and calculated at an average load of
3.1 g day1 during the sampling period. Similar to the ATS drugs,
higher levels in the breakdown products of cocainewas observed in
the wastewater influent (benzoylecgonine >
cocaethylene > cocaine) (Fig. 2). The drug-precursor and nasal
decongestant, (pseudo)ephedrine, was detected at an average
concentration of 6321 ng L1 (269.4 g day1) (Table S3). Norephe-
drine was detected at an average concentration of 1519 ng L1
(65.1 g day1). In comparison, the levels of ephedrine and nor-
ephedrine ranged between 8.7 and 1979.5 ng L1 (median load of
16.5 g day1) and 15.0e99.9 ng L1 respectively at the influent of sixters, and sampling locations upstream and downstream from the plant.
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levels were noticeably lower than reported in the current study.
Although (pseudo)ephedrine is generally used as an over-the-
counter nasal decongestant, a report by the South African Depart-
ment of Social Development mentioned that South Africa is one of
the largest importers of (pseudo)ephedrine in the world (CDA,
https://www.cda.gov.za), which explains the high levels of the
compound detected in the current study.
It is worthy to mention that the sources of ATS drugs in surface
waters might vary. Methamphetamine is shown to be metabolised
to amphetamine by de-methylation enzymes from the CYP2D6
gene (De la Torre et al., 2012), whereas amphetamine is also an
active ingredient in medication for the treatment of attention
deficit hyperactivity disorder (ADHD). Therefore, the presence of
certain compounds could not be attributed to a specific source of
exposure or drug abuse. The levels detected for methamphetamine
(271e450 ng L1; 15.2 g day1), cocaethylene (186e225 ng L1;
8.8 g day1), and (pseudo)ephedrine (283e16640 ng L1;
269.4 g day1) in the WWTW influent (Tables S2 and S3) were
detected at much higher levels than reported for UK WWTWs
(Petrie et al., 2014). The current study therefore highlights the us-
age of sewage samples to indicate the trends of drug abuse within a
community, and may therefore serve as a valuable tool in epide-
miological studies.
3.3. ECs in environmental waters
A total of 40 ECs were detected in surface waters located up-
stream and downstream of the plant during the sampling period
(Table 1). The levels of diclofenac, ibuprofen, ketoprofen, sulfa-
methoxazole, and bezafibrate were also analysed in other South
African surface waters, and were detected at higher concentrations
than in the current study (Agunbiade and Moodley, 2016). How-
ever, the average concentrations of the measured ECs in surface
water during the current study showed that 30 of the 40 detected
ECs (75%) were higher than found in UK surfacewaters (Petrie et al.,
2014; Petrie et al., 2016). Although methylparaben, bisphenol-A,
nicotine, cotinine, caffeine, and 1,7-dimethylxantine were
removed with moderate to high efficiency by the WWTW (Fig. 2),
the average concentrations of these compounds were calculated to
be higher in downstream samples compared to the WWTW
effluent (Table S2). However, only the levels of nicotine were found
to be significantly higher in downstream samples compared to
WWTW effluent samples during the sampling period (p < 0.05),
mainly due to large variations of the other EC levels during the
sampling period and also due to composite samples which were
taken at the WWTW effluent and grab samples taken at the
downstream site. In contrast, by comparing the average levels of
ECs at the upstream and downstream sampling sites, it was shown
that 26 out of the 40 detected ECs in surface waters (65%) were
found to be two-fold or higher in downstream samples, with co-
deine detected higher than 10 fold (Table 1). The concentrations of
ECs in surface waters are known to not only fluctuate on a seasonal
or daily basis, but also in distance from the plant (Vieno et al.,
2005). The higher levels of some PPCPs detected at downstream
samples may therefore largely be attributed to the distance be-
tween the WWTW effluent and downstream sampling points
(3500 m from the point of discharge), and fluctuations in the
concentrations of the detected compounds between sampling days
could also be attributed to variations in river water flow rates be-
tween sampling days.
The fact that human indicator compounds (such as nicotine)
were detected at higher average levels in the downstream samples
relative to theWWTWeffluent samples (Table S2) indicates human
activities further downstream from the WWTW, which could havere-introduced some ECs (such as methylparaben, codeine and
bisphenol-A) back into the water system after the levels of the
pollutants were lowered at the plant. The direct discharge and/or
illegal dumping of sewage and other waste products may have been
a contributing factor to these observations. This might also explain
the high fold-increase in codeine further downstream of the plant
(Table 1), which is regarded as the most abused over-the-counter
drug in the country. However, the difference in mode of sampling
should also be pointed out; composite samples were taken at the
WWTW, whereas grab samples were taken for the river water,
which should be corrected in future studies. Some industrial (such
as a brick manufactory) and agricultural practices (poultry and
other livestock) are present between the point of discharge of the
WWTW and the downstream sample taken in the study. The
presence of PPCPs and some metabolites point to other waste
sources and human activities further downstream from the
WWTW.
3.4. Environmental risk of the detected pollutants
The demonstrated presence of a vast mixture of ECs in WWTW
effluent and river water in the current study emphasises the need
to consider potential associated environmental risks. Conventional
methods for environmental risk assessment (ERA) includes acute-
and/or chronic toxicity data based on the most sensitive organism
or combination of organisms within a given ecosystem to deter-
mine a predicted no-effect concentration (PNEC) of an environ-
mental pollutant. This value is then compared to predicted- or
measured environmental concentrations (PEC or MEC respectively)
to obtain a risk quotient (RQ) of the EC of interest. An RQ value
exceeding 1.0 is then regarded as an environmental risk. Table S4
reports on RQs determined for some ECs which were detected in
WWTW effluent and river water during the current study. The
MECs show that 5 out of the 41 detected ECs in WWTW effluent,
and 4 of the 40 detected ECs in environmental surface waters posed
an environmental risk (RQ > 1; Table S4). These ECs included
diclofenac, sulfamethoxazole, clarithromycin, codeine, and nico-
tine, with clarithromycin only showing an environmental risk for
WWTW effluent water (RQ > 1), although still of environmental
relevance (RQ ¼ 0.8; Table S4).
Although conventional ERA is valuable to show toxicity risks of
ECs found in environmental waters, a few limitations exist. These
models only consider lethal toxicity on an in vivo level as a risk
endpoint and hence, the consequences of pollutants triggering sub-
lethal toxicity on physiological pathways (from molecular to
cellular level) are highly underestimated. The possibility of PPCPs to
modulate molecular and/or cellular pathways (such as those
involved in endocrine system function) at concentrations well
below lethal toxicity therefore makes such outcomes more
ecologically relevant for risk assessment. To assist with the un-
derstanding of toxicity mechanisms leading towards an observed
adverse outcome on a population level, an adverse outcome
pathway (AOP) framework has been proposed (Ankley et al., 2010).
This conceptual framework is aimed towards using existing toxi-
cological knowledge to establish a relationship between biological
events on cellular-to organism level (termed key events, KEs)
through key event relationships (KERs), which is initiated by a
molecular initiating event (MIE) (Villeneuve et al., 2014; Margiotta-
Casaluci et al., 2016). The KERs are dependent on a weigh-of-
evidence approach to show the relationship between established
KEs. The downstream KEs through biological complexity subse-
quently lead towards an observed adverse outcome (AO) which can
be used for environmental regulatory decision-making (Ankley
et al., 2010). Although the AOP framework is not directly con-
structed to be chemical specific, nor to serve as a risk assessment
Fig. 2. Mass loads (g day1) for the detected compounds at the WWTW during the sampling period. Values are expressed on a logarithmic scale. The standard deviations shows variation between sampling days. NSAIDs: non-steroidal
anti-inflammatory drugs, EPH/pEPH: ephedrine/pseudoephedrine, dh-hCBZ: 10,11-dihydro-10-hydroxycarbamazepine, CBZ-ep: carbamazepine-10,11-epoxide, DMX: 1,7-dimethylxantine, NDT: N-desmethyltramadol, ODT: O-desme-













Fig. 3. Removal efficiencies (%) of the detected compounds at the WWTW during the sampling period. Standard deviations indicate variation in between sampling days. NSAIDs: non-steroidal anti-inflammatory drugs, EPH/pEPH:
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studies (such as the current study) can therefore show the possi-
bility of ECs in environmental waters to modulate certain MIEs or
KEs. As a result, RQ values can be generated for certain MIEs and
KEs (RQMIE/RQKE) in a similar way as conventional ERA. Such risk
predictions can therefore serve as early warning systems to pri-
oritise ECs for their potential to contribute towards possible
detrimental health effects in the environment.
Several studies have suggested that organic pollutants can
modulate endocrine system pathways of vertebrate species at low
concentrations which are regularly detected in the environment.
In vitro studies have shown, for example, that the plasticizers
bisphenol-A, disinfection products (such as parabens), and UV fil-
ters can induce MIEs such as agonistic binding to the human oes-
trogen receptor (hER), which has further been shown to lead
towards the proliferation of breast cancer cells (Schlumpf et al.,
2001; Boberg et al., 2010). Exposure of fish to paraben and UV fil-
ter compounds have been reported to induce MIEs and KEs such as
increased expression of mRNA transcripts of the oestrogen recep-
tor-a (ERa) and protein vitellogenin (VTG) in the liver of male fish,
which can be linked to further downstream KEs such as increased
levels of plasma VTG in the body (Inui et al., 2003; Barse et al.,
2010). The protein VTG is a precursor of egg yolk in oviparous an-
imals, and serves as a common biomarker to show oestrogenic
endocrine disruption in aquatic organisms due to its direct KERs
with circulating androgen- and oestrogen hormone levels (Jones
et al., 2000; AOP-Wiki, KE219 & KE285). The relevant MIEs and
KERs leading towards increased VTG production has been well
documented to be directly linkedwith KEs on organismal level such
as fecundity and spawning, which can eventually have an effect on
population trajectories (AOP-Wiki, AOP25). Although it has been
shown in the current study that parabens and UV filters are
effectively-to moderately removed in the WWTW (Fig. 2), meth-
ylparaben, benzophenone-4, and benzophenone-3 were still
detected in river water downstream of the plant (Table 1), albeit
well-below reported levels to modulate KEs as shown in laboratory
studies (Inui et al., 2003; Barse et al., 2010) (RQKE ≪ 1; Table S4).
Exposure of other pharmaceuticals, such as the NSAIDs diclo-
fenac and ibuprofen have also been shown to modulate KEs such as
elevated plasma oestradiol levels and induction of VTG in male fish,
either through upregulation of upstream MIEs (such as increased
aromatase activity) or other molecular targets (Hong et al., 2007;
Han et al., 2010; Gr€oner et al., 2017; Table S4). Although the con-
centrations to modulate these observed estrogenic endpoints are
higher than the environmental concentrations for ibuprofen in the
current study, the concentration of diclofenac in WWTW effluent
and river water samples regularly exceeded the 1000 ng L1 value
previously reported to modulate VTG production in fish (Hong
et al., 2007; RQKE > 1; Table S4). Although an increase in VTG
production has been shown for diclofenac at 1000 ng L1, Gr€oner
et al. (2017) mentioned that such a concentration, however, does
not impair population-relevant endpoints such as survival and
hatching success. On the contrary, both ibuprofen and naproxen
have been reported to cause decreased egg fertilisation in fish at a
concentration of 100 ng L1 (Nesbitt, 2011), which therefore reflects
upon modulation of an established KE of fecundity and spawning
(AOP-Wiki, KE78). The concentrations of ibuprofen and naproxen
within WWTW effluent and river water during the current study
were well above the threshold to potentially modulate such a KE
(RQKE > 1; Table S4), and therefore indicates a potential environ-
mental risk to impair fecundity and spawning, which can ulti-
mately lead to a decline in fish populations (AOP-Wiki, AO360).
Whether the concentrations of these NSAIDs is sufficient to induce
further downstream KEs, or can be extrapolated to other vertebrate
species need further investigation.Apart from NSAIDs showing reproductive endocrine disruption
in aquatic organisms, in vivo exposure of 500 ng L1 carbamazepine
in water has been shown to cause significant reduction in plasma
11-ketotestosterone (11-KT) concentrations in male fish (Galus
et al., 2013a), of which the upstream MIE causing this endpoint is
still unknown. 11-KT is the primary teleost androgen necessary for
normal reproductive functioning, and hence, also influence the
reproductive success of fish populations. The average concentration
of carbamazepine in the WWTW effluent of the current study was
close to the 500 ng L1 threshold which can cause such a reduction
in fish steroid hormone levels (Table S4). Although the modulation
of circulating 11-KT is not shown to lead towards altered oestradiol
hormone synthesis through aromatase enzyme activities (such as
the case with circulating testosterone levels), the modulation of
circulating 11-KT levels in fish can still be regarded as a potential KE
to lead towards reproductive dysfunction in male fish. Further-
more, no studies have been conducted to report on the potential
endocrine disrupting effect of the primary metabolites of carba-
mazepine, which was shown to be detected at higher concentra-
tions within WWTW effluent and river water (Fig. 2; Table 1), and
removed to a lower extent in the WWTW (Fig. 3). We therefore
propose that this compound and its metabolites need further
monitoring for its potential to cause detrimental effects in aquatic
vertebrates, especially due to its demonstrated recalcitrance and
potential to modulate androgen-controlled endocrine pathways.
Apart from the potential of ECs to modulate reproductive endo-
crine system pathways, studies showing modulation of the thyroid
endocrine system have also been reported. Exposure of the NSAID
ibuprofen to tadpoles of the American bullfrog (Rana catesbeiana) at
concentrations ranging from1500 to15000ngL1 havebeen shown
to potentiate triiodothyronine (T3)-induced mRNA transcription of
thyroid hormone receptors (Veldhoen et al., 2014). In the same
study, exposure to ibuprofen alone resulted in increased mRNA
transcripts for enzymes such as thyroxine 5-deiodinase (dio3) in a
tail fin tissue assay, which is necessary to regulate thyroid hormone
homeostasis (Veldhoenet al., 2014). Although the levels of ibuprofen
observed in the present study was below these concentrations in
both theWWTWeffluent and riverwater, the levels of otherNSAIDs,
such as naproxen (average concentration of 2296 ng L1 inWWTW
effluent; Table S2) and diclofenac (average concentration of
2326 ng L1 in WWTW effluent; Table S2), fell within the concen-
tration range to possibly alter such MIEs, given that these NSAIDs
yield the same mechanism of endocrine disruption as ibuprofen. It
has been shown that diclofenac (but not naproxen) can antagonis-
tically bind to the thyroid hormone receptor-b (thrb) in a human
reporter assay, and also inhibit T3-induced vasodilation of rat
mesenteric arteries (Zloh et al., 2016). Also, it is important to note
that cross-talk between endocrine system pathways exist. For
example, Nelson and Habibi (2016) demonstrated an increased
production of VTG and upregulation of ERa following a treatment of
T3 in female goldfish (Carassius auratus). Therefore, the potential of
NSAIDs to alter both thyroid- and gonadal endocrine system path-
ways can be linked to several KEs and KERs, given that the concen-
trations and bioaccumulation of these pollutants are sufficient
within the organisms to exert such effects. However, relatively little
has been done to assess the impact of NSAIDs on whole-life cycles
within aquatic organisms, and should receive more attention in
future studies, especially due to their ease of purchase, their regular
usage, and moderate persistence in the aqueous phase at WWTWs
as shown in the current study. These results therefore indicate the
importance to regard NSAIDs as priority environmental EDCs in
future studies.
Another complication which arise in establishing ECs as an
environmental risk is the complex range of interactions that are
found in environmental waters. Several ECs generally accumulate
Table 1
Mean concentrations (ng L1) of detected PPCPs, metabolites, illicit drugs and human indicator compounds at sampling localities located upstream and downstream of the
WWTW. Standard deviation indicate variation between sampling days for the compounds. Abbreviations: NSAIDs: non-steroidal anti-inflammatory drugs, EPH/pEPH:
ephedrine/pseudoephedrine, dh-10-hCBZ: 10,11-dihydro-10-hydroxycarbamazepine, CBZ-ep: carbamazepine-10,11-epoxide, DMX: 1,7-dimethylxantine, NDT: N-desme-
thyltramadol, ODT: O-desmethyltramadol.
Upstream Downstream Fold change Upstream Downstream Fold change
Average Stdev Average Stdev Average Stdev Average Stdev
Parabens Anti-epileptic
Methylparaben 58.7 29.2 146.1 107.3 2.5 Carbamazepine 157.1 11.5 279.5 24.1 1.8
Propylparaben 31.8 17.4 136.7 76.8 4.3 CBZ-ep 398.8 27.9 752.2 69.4 1.9
dh-hCBZ 22.7 1.58 56.9 8.9 2.5
UV filters
Benzophenone-3 56.2 1.7 64.3 6.0 1.1 Diabetes
Benzophenone-4 441.1 23.8 1076.5 389.6 2.4 Gliclazide 43.2 2.4 53.9 22.3 1.3
Metformin 73.3 7.2 174.6 81.7 2.4
Plasticizer
Bisphenol-A 239.0 72.1 396.4 208.1 1.7 Hypertensions
Irbesartan 311.1 28.7 554.4 120.0 1.8
Antibiotics Valsartan 263.7 24.6 924.7 50.2 3.5
Azithromycin 24.6 0 6.4 3.4 0.3
Clarithromycin 76.2 13.4 235.5 66.1 3.1 Anti-depressants
Sulfamethoxazole 757.4 83.2 1013.2 294.2 1.3 Fluoxetine 34.4 22.1 109.2 125.6 3.2
Sulfasalazine 37.6 3.4 53.0 13.0 1.4 Venlafaxine 35.4 3.7 94.6 19.6 2.7
Trimethoprim 383.0 42.2 898.7 303.0 2.4 Desvenlafaxine 50.0 7.5 174.9 53.8 3.5
NSAIDs Analgaesics
Acetaminophen 20.8 4.5 63.7 76.1 3.1 Codeine 11.3 6.7 128.9 65.4 11.5
Diclofenac 467.4 176.2 1461.5 508.7 3.1 Tramadol 97.7 11.2 299.9 73.2 3.1
Ibuprofen 153.3 39.5 312.1 204.6 2.0 NDT 16.0 9.9 74.0 8.1 4.6
Ketoprofen 642.2 0 330.3 319.0 0.5 ODT 207.6 32.2 577.3 149.8 2.8
Naproxen 224.3 31.1 1112.8 518.3 5.0
Drug precursor
Lipid regulators Eph/pEPH 38.8 8.0 80.4 28.4 2.1
Atorvostatin 74.0 5.2 150.6 55.7 2.0
Bezafibrate 54.9 8.3 234.4 116.8 4.3 Stimulants
Amphetamine 27.1 22.6 37.0 22.6 1.4
Antihistamine
Fexofenadine 368.4 36.7 887.0 172.0 2.4 Human indicators
Nicotine 154.3 78.7 245.5 67.6 1.6
X-ray contrast media Cotinine 25.5 3.3 31.7 11.7 1.2
Iopromide 265.8 11 598.3 235.4 2.3 Caffeine 812.2 146.3 2077.5 259.7 2.6
DMX 479.4 357.6 957.6 728.6 2.0
Beta-blockers
Atenolol 156.2 34.43 272.0 154.6 1.7
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types of organic and inorganic pollutants), inwhich themodulating
effects of such mixtures may differ from observed effects of the
individual pollutants. For example, a study by Galus et al. (2013b)
showed a mixture of environmentally relevant concentrations of
acetaminophen, carbamazepine, gemfibrozil, and venlafaxine
(500 ng L1 for each compound) significantly altered embryo pro-
duction, oocyte development, and fecundity in female zebrafish
(Danio rerio), while the individual compounds exposed to the fish
species at the same concentrations did not yield the same results
(Galus et al., 2013a). Although investigations of PPCP mixture ef-
fects generate a more ecologically relevant scenario, it is more
feasible to identify the KEs and KERs which are modulated by in-
dividual compounds, which may ultimately lead to a better un-
derstanding of the health risks in environmental waters. The fact
that some ECs in the current study showed low removal from the
WWTW, as well as the possibility to cause adverse effects on
vertebrate endocrine system pathways (such as carbamazepine, UV
filters, plasticizers, parabens and NSAIDs) highlights the impor-
tance to further monitor these priority ECs to limit their impact on
both the aquatic ecosystem and contamination to drinking water
resources.
4. Conclusions
The current study aimed to provide a link between themonitoring of ECs in WWTWs and environmental waters with
possible adverse health consequences in wildlife. Although most
ECs were shown to be notably reduced in WWTW effluent, some
persisted, and were even detected at higher concentrations in
effluent (as shown for some pharmaceutical metabolites and
parental compounds). It is therefore important to report on the fate
of both parental ECs as well as their metabolites and/or conjugate
forms in surface waters to elucidate the possible negative mass
balances observed in WWTWs and recalcitrance of pollutants in
environmental waters.
Drawing definite conclusions regarding the health impact
which these pollutants may cause when entering environmental
waters is no simple task, considering that these pollutants are
present in complex mixtures with varying physiochemical
properties, as well as their varying affinities to modulate a range
of molecular and cellular pathways in wildlife species. It is
therefore clear that there is a need for more eco-toxicological
assessment on the sub-lethal effects of ECs and polluted water
systems into identifying MIEs, KEs and KERs which certain ECs
can modulate to advance current risk assessment approaches.Conflict of interest
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